中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝硬化并发菌血症研究进展

王静云 孙晶 高沿航

引用本文:
Citation:

肝硬化并发菌血症研究进展

DOI: 10.3969/j.issn.1001-5256.2014.07.030
基金项目: 

国家自然科学基金(81001312); 

详细信息
  • 中图分类号: R575.2

Research advances in liver cirrhosis complicated by bacteremia

Research funding: 

 

  • 摘要: 菌血症是肝硬化患者的常见并发症,肝硬化菌血症的发生率随肝病严重程度递增,一旦发生菌血症,则提示预后较差。叙述了肝硬化并发菌血症的危险因素、诊断要点、治疗方法、预防及预后五个方面的研究进展,认为早期防治菌血症对肝硬化患者的预后有重要意义。

     

  • [1]FERNNDEZ J, NAVASA M, GMEZ J, et al.Bacterial infections in cirrhosis:epidemiological changes with invasive procedures and norfloxacin prophylaxis[J].Hepatology, 2002, 35 (1) :140-148.
    [2]BUNCHORNTAVAKUL C, CHAVALITDHAMRONG D.Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis[J].World J Hepatol, 2012, 4 (5) :158-168.
    [3]GHASSEMI S, GARCIA-TSAO G.Prevention and treatment of infections in patients with cirrhosis[J].Best Pract Res Clin Gastroenterol, 2007, 21 (1) :77-93.
    [4]BELLOT P, FRANCS R, SUCH J.Pathological bacterial translocation in cirrhosis:pathophysiology, diagnosis and clinical implications[J].Liver Int, 2013, 33 (1) :31-39.
    [5] HASHIMOTO N, OHYANAGI H.Effect of acute portal hypertension on gut mucosa[J].Hepatogastroenterology, 2002, 49 (48) :1567-1570.
    [6]YIN XJ.Risk factors for liver cirrhosis combined with nosocomial infections[J].Chin J Nosocomiol, 2012, 22 (8) :1624-1625. (in Chinese) 殷晓俊.肝硬化合并医院感染的危险因素分析[J].中华医院感染学杂志, 2012, 22 (8) :1624-1625.
    [7]HARTMANN P, CHEN WC, SCHNABL B.The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease[J].Front Physiol, 2012, 3:402.
    [8]PAPP M, VITALIS Z, ALTORJAY I, et al.Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections[J].Liver Int, 2012, 32 (4) :603-611.
    [9]LI CH, YANG RB, PANG JH, et al.Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department[J].Acad Emerg Med, 2011, 18 (2) :121-126.
    [10]JEONG S, PARK Y, CHO Y, et al.Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture[J].Clin Chim Acta, 2012, 413 (21-22) :1731-1736.
    [11]YILMAZ G, MENTESE A, KAYA S, et al.The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in Crimean-Congo hemorrhagic fever[J].J Clin Virol, 2011, 50 (3) :209-211.
    [12]HUTTUNEN R, SYRJNEN J, VUENTO R, et al.Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia:a prospective cohort study[J].J Intern Med, 2011, 270 (1) :32-40.
    [13]GAO K, ZHANG LF.Progress in interleukin and tumors[J].Chin J Immunol, 2012, 28 (5) :467-470. (in Chinese) 高昆, 张连峰.白细胞介素与肿瘤研究进展[J].中国免疫学杂志, 2012, 28 (5) :467-470.
    [14]HOENIGL M, RAGGAM RB, WAGNER J, et al.Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome[J].Clin Biochem, 2013, 46 (3) :225-229.
    [15]GUSTOT T, DURAND F, LEBREC D, et al.Severe sepsis in cirrhosis[J].Hepatology, 2009, 50 (6) :2022-2033.
    [16]GUO TS, QU F, MAO YL, et al.Research on the distribution and antibiotics resistance sepectrum of bacteria isolated from blood cultures in patients with chronic hepatopathy[J].J Int Inten Med, 2006, 12 (3) :105-107. (in Chinese) 郭桐生, 曲芬, 毛远丽, 等.慢性肝病患者血培养分离菌分布特征及耐药谱研究[J].内科急危重症杂志, 2006, 12 (3) :105-107.
    [17]SHIZUMA T, FUKUYAMA N.Investigation into bacteremia and spontaneous bacterial peritonitis in patients with liver cirrhosis in Japan[J].Turk J Gastroenterol, 2012, 23 (2) :122-126.
    [18] PATERSON DL, BONOMO RA.Extended-spectrum beta-lactamases:a clinical update[J].Clin Microbiol Rev, 2005, 18 (4) :657-686.
    [19]SKOV R, CHRISTIANSEN K, DANCER SJ, et al.Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA) [J].Int J Antimicrob A-gents, 2012, 39 (3) :193-200.
    [20]FELDMAN C, ANDERSON R.Bacteraemic pneumococcal pneumonia:current therapeutic options[J].Drugs, 2011, 71 (2) :131-153.
    [21]ARIAS CA, MENDES RE, STILWELL MG, et al.Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections[J].Clin Infect Dis, 2012, 54 (Suppl 3) :s233-s238.
    [22]ANTHONY KB, FISHMAN NO, LINKIN DR, et al.Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline[J].Clin Infect Dis, 2008, 46 (4) :567-570.
    [23]VILA J, MARCO F, SOLER L, et al.In vitro antimicrobial susceptibility of clinical isolates of Aeromonas caviae, Aeromonas hydrophila and Aeromonas veronii biotype sobria[J].J Antimicrob Chemother, 2002, 49 (4) :701-702.
    [24]ARVANITI V, D'AMICO G, FEDE G, et al.Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis[J].Gastroenterology, 2010, 139 (4) :1246-1256.e1-5.
    [25]WU HQ, WANG H.Diagnosis and treatment of spontaneous bacterial peritonitis in patients with liver ascite[J].J Clin Hepatol, 2012, 28 (9) :651-653. (in Chinese) 吴海清, 王晖.肝硬化腹水伴自发性细菌性腹膜炎的诊断及治疗[J].临床肝胆病杂志, 2012, 28 (9) :651-653.
  • 加载中
计量
  • 文章访问数:  2431
  • HTML全文浏览量:  6
  • PDF下载量:  698
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-09-02
  • 出版日期:  2014-07-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回